Scientists develop technique for better detection of breast cancer

Japan |  News | 0 Comment | 24 May, 2019

Researchers at Okayama University report in the journal Sensors and Actuators B: Chemical that terahertz radiation can be used to rapidly detect makers for breast-cancer cells.&nb...Read more

Menicon launches Menicon Bloom Myopia Control Management System

Japan |  News | 0 Comment | 24 May, 2019

Menicon Co. has announced the launch of the Menicon Bloom Myopia Control Management System, a holistic approach for myopia control management. The launch features the initial intr...Read more

B dot Medical to develop ultra-compact proton cancer therapy

Japan |  News | 0 Comment | 24 May, 2019

B dot Medical Inc. has announced that the company has initiated the development of an ultra-compact proton cancer therapy system that can replace the commonly used x-ray cancer therapy...Read more

Chugai’s Actemra Intravenous Infusion receives additional approval for Adult Still’s Disease

Japan |  News | 0 Comment | 24 May, 2019

Chugai Pharmaceutical has announced that it has obtained regulatory approval for the humanized anti-human IL-6 receptor monoclonal antibody, “Actemra® Intravenous Infusion 80...Read more

Japan approves use of Elekta Unity MRI therapy system

Japan |  News | 0 Comment | 24 May, 2019

Elekta (EKTA-B.ST) has announced that its Elekta Unity magnetic resonance radiation therapy system has been approved for clinical use in Japan. Elekta Unity combines two technologies:...Read more

Eisai brings Novartis executive on oncology board

Japan |  News | 0 Comment | 23 May, 2019

Eisai Inc., the U.S. pharmaceutical subsidiary of Japan headquartered Eisai Co., Ltd., has announced the immediate appointment of Dr. Luca Dezzani as Vice President, U.S. Medical ...Read more

Takeda, Frazier Healthcare Partners to launch Phathom Pharma

Japan |  News | 0 Comment | 21 May, 2019

Takeda Pharmaceutical and Frazier Healthcare Partners have announced a collaboration to launch Phathom Pharmaceuticals, a biopharmaceutical company focused on the development and commercial...Read more

Takeda announces results of Phase 3b VARSITY studies

Japan |  News | 0 Comment | 20 May, 2019

Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, which demonstrated that the gut-selective biologic vedolizumab (Entyvi...Read more

Daiichi Sankyo fails to hold up influenza vaccine project

Japan |  News | 0 Comment | 20 May, 2019

Japanese pharma company Daiichi Sankyo has announced that the Company has been unable to fulfill its obligation to build a scheme to supply vaccines for 40 million people in the time allott...Read more

Eisai to present data on oncology pipeline and products

Japan |  News | 0 Comment | 16 May, 2019

Eisai Co., Ltd. announced that presentations on a series of abstracts highlighting updates regarding its in-house discovered lenvatinib mesylate (product name: Lenvima, "lenvatinib", kinase...Read more

Teijin and AMED to develop drugs for frail elders

Japan |  News | 0 Comment | 17 May, 2019

Teijin Limited has announced that it has signed a research and development agreement with the Japan Agency for Medical Research and Development (AMED) to form an industry-government-academi...Read more

Takeda's BLA for Vedolizumab gets approval by U.S. FDA

Japan |  News | 0 Comment | 14 May, 2019

Takeda Pharmaceutical Company has announced that the U.S. Food & Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for a subcutaneous (SC) for...Read more

Daiichi Sankyo launches hypertension drug in Japan

Japan |  News | 0 Comment | 15 May, 2019

Daiichi Sankyo has announced the launch in Japan of MINNEBRO® Tablets 1.25 mg, 2.5 mg and 5 mg (generic name: esaxerenone; hereafter, the drug). The drug is a novel, non-steroidal...Read more

Eisai to sell anti-rheumatic injection in Japan

Japan |  News | 0 Comment | 14 May, 2019

Eisai Co., Ltd. has entered into a license agreement with medac Gesellschaft für klinische Spezialpräparate mbH (Medac) for the commercialization of its anti-rheumatic agent metho...Read more

Takeda sells surgical patch to Ethicon for $400M

Japan |  News | 0 Comment | 13 May, 2019

Japan headquartered Takeda Pharma has entered into an agreement to sell TachoSil®, a surgical patch designed to achieve safe, fast and reliable bleeding control, to Ethicon, a subsidiar...Read more

Novartis to acquire Xiidra in a $5.3B deal

Japan |  News | 0 Comment | 10 May, 2019

Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with Xiidra® (lifitegrast ophthalmic solution) ...Read more

Promethera Biosciences makes progress in HepaStem development programme

Japan |  News | 0 Comment | 09 May, 2019

Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a first patient in a Phase 2a clinical study for the company’s He...Read more

Promethera Biosciences completes €39.7 M Series D Financing

Japan |  News | 0 Comment | 08 May, 2019

Promethera Biosciences, a global innovator in cell-based medicines and liver diseases has announced the closing of a €39.7 million (JPY4.94 billion) Series D financing. The round...Read more